A global policy would reward firms which strive for higher quality.
USFDA consent decree reveals that firm will have to forego huge short-term opportunities for its generics.
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
'India is too large a place to have just 10 labs performing these Covid-19 tests.'
The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.
The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.
GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.
India's largest drug manufacturer, Ranbaxy Laboratories, had falsified data and test results of medicines manufactured at its Himachal Pradesh facility to obtain marketing approval in the United States, says the US Food and Drug Administration.
The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.
Beside the defence forces in India, the start-up has shipped around 350,000 units to 12 countries -- the United Kingdom, France, Poland, Bangladesh, Saudi Arabia, the UAE, Kenya, South Africa, Romania, Indonesia, Qatar and Oman.
Despite the ongoing trouble India's largest drug maker, Ranbaxy, is facing in the United States, domestic pharmaceutical companies are betting high on the world's largest drug market with added vigour.
Last year, the USFDA had banned 30 generic drugs produced at Ranbaxy's plants at Poanta Sahib.
US experts were pondering on the safety of food imported into US from developing countries. In lieu of this thought process, a new trend has emerged in America of preferring locally produced food. This trend is affecting Wal Mart and Whole Foods too. It has been observed that when food travels far, the local community are the least benefitted out of the exports. But the trend to grow more locally will seriously affect nations that depend largely on agricultural exports.
Amid reports of a US Congress probe against India's largest drug maker Ranbaxy Laboratories, data show that many leading multinational companies such as Pfizer, GlaxoSmithKline, Novartis and Merck are also under the scanner of the US drug regulator, for more or less similar violations as Ranbaxy is alleged to have committed.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
He said action was akin to holding highway builders responsible for lane violations
Two United States senators have asked the US Food and Drug Administration (USFDA) to provide details of market approvals given to all medicines sold by India's largest drug-maker Ranbaxy in that country.
Analysts say those taking exposure through stocks could look at firms focused on domestic business
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
The matter is now expected to be raised with the PMO.
Regulator's nod assumed more importance after the Maggi issue.
The procedure, however, would cost around Rs 75,000-100,000 more than conventional angioplasty.
In May this year, Ranbaxy had pleaded guilty to 'felony charges' for violating manufacturing norms and agreed to pay $500 million penalty to US authorities.
We are surrounded by food that is contaminated, adulterated and does not meet Indian safety and packaging standards, says Abheet Singh Sethi/IndiaSpend.com.
Check out some of the stocks that will react on the basis of their numbers in the near term.
Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma treatments
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Experts question Nestle's silence over Maggi controversy.
India and the US should not get into any lengthy investigations for business related concerns.
'Let me talk about young Indian startups with their hearts in the right place and how they are proving that innovations that represent 'affordable excellence' -- breaking the myth that 'affordability' and 'excellence' cannot go together -- is indeed possible!' says Dr R A Mashelkar, the eminent scientist, in this fascinating feature.
Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.
In its daily briefing, the government also reported Goa is now free of coronavirus.
Maggi banned in Delhi for 15 days.
Kapiva's plans to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer finds traction.
The state government had in the first week of June banned Maggi sale in the state after the product failed the food safety test.
The introduction of e-pharmacy, to protect the interest of a handful of players, would hamper the interest of 800,000 chemists and 80 lakh workers and their families
Financials were the top losers while oil shares also declined amid weak crude oil prices.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances